logo

Last Update

This profile was last updated on 7/13/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Douglas Bakan?

Douglas A. Bakan

Drug Development, CMC, and Regulatory

Consultant Associates Ltd

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Consultant Associates Ltd

Background Information

Employment History

Vice President of Business Development

Alerion Biomedical Inc.


Vice President, Product Development

Novalar Pharmaceuticals , Inc.


Vice President of Business Development At Alerion Biomedical

MetaProbe Inc


Senior Director of Development

Neurocrine Biosciences , Inc.


Director of Pharmaceutical Formulations and Manufacturing

Corvas International , Inc.


Associate Director of Product Development

Molecular Biosystems , Inc.


Vice President, Product Development

Medicis Pharmaceutical Corporation


Affiliations

Bells of Freedom

Board Member


Education

BS

bioengineering

University of California , San Diego


Ph.D.


PhD

biochemistry and physiology

University of California , San Diego


Web References(12 Total References)


CHI, Cambridge Healthtech Institute

www.chidb.com [cached]

Douglas A. Bakan, Ph.D., Alerion Biomedical, Inc.


Novalar - Specialty Pharmaceuticals- Leadership Team

www.novalar.com [cached]

Doug Bakan, PhD
Vice President, Product Development Dr. Bakan joined Novalar in May 2008 as Vice President, Product Development. Dr. Bakan brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies. Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems. He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra™ line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC,; Director of Pharmaceutical Formulations and Manufacturing at Corvas International; and Associate Director of Product Development at Molecular Biosystems, Inc. Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging. Dr. Bakan earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work in the Department of Pharmacology at the University of Michigan.


Novalar Management

www.novalarpharm.com [cached]

Doug BakanVice President, Product DevelopmentDoug Bakan joined Novalar in May 2008 as Vice President, Product Development.Dr. Bakan brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies.Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems.He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC, a start-up company focused on developing biochemically activated imaging agents; Director of Pharmaceutical Formulations and Manufacturing at Corvas International, a company focused on developing drugs treating cardiovascular disease and cancer; and Associate Director of Product Development at Molecular Biosystems, Inc., where Albunex® and Optison®, the first cardiac ultrasound imaging agents, were developed and commercialized during his tenure.Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging.Doug earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work at the University of Michigan.


www.novalar.com

Doug BakanVice President, Product DevelopmentDoug Bakan joined Novalar in May 2008 as Vice President, Product Development.Dr. Bakan brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies.Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems.He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC, a start-up company focused on developing biochemically activated imaging agents; Director of Pharmaceutical Formulations and Manufacturing at Corvas International, a company focused on developing drugs treating cardiovascular disease and cancer; and Associate Director of Product Development at Molecular Biosystems, Inc., where Albunex® and Optison®, the first cardiac ultrasound imaging agents, were developed and commercialized during his tenure.Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging.Doug earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work at the University of Michigan.


Aleriion Biomedical is Featured at the Annual Meeting of the Academy of Molecular Imaging

www.freshnews.com [cached]

"Dozens of leading researchers around the world have already seen Fenestra's value with their own eyes," said Alerion's Vice President, Dr. Douglas Bakan.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory